Cargando…
Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994726/ https://www.ncbi.nlm.nih.gov/pubmed/34643774 http://dx.doi.org/10.1007/s00345-021-03849-5 |
| _version_ | 1784684167174291456 |
|---|---|
| author | Tsaur, Igor Brandt, Maximilian P. Juengel, Eva Manceau, Cécile Ploussard, Guillaume |
| author_facet | Tsaur, Igor Brandt, Maximilian P. Juengel, Eva Manceau, Cécile Ploussard, Guillaume |
| author_sort | Tsaur, Igor |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8994726 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89947262022-04-22 Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes Tsaur, Igor Brandt, Maximilian P. Juengel, Eva Manceau, Cécile Ploussard, Guillaume World J Urol Correction Springer Berlin Heidelberg 2021-10-13 2022 /pmc/articles/PMC8994726/ /pubmed/34643774 http://dx.doi.org/10.1007/s00345-021-03849-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Tsaur, Igor Brandt, Maximilian P. Juengel, Eva Manceau, Cécile Ploussard, Guillaume Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes |
| title | Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes |
| title_full | Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes |
| title_fullStr | Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes |
| title_full_unstemmed | Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes |
| title_short | Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes |
| title_sort | correction to: immunotherapy in prostate cancer: new horizon of hurdles and hopes |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994726/ https://www.ncbi.nlm.nih.gov/pubmed/34643774 http://dx.doi.org/10.1007/s00345-021-03849-5 |
| work_keys_str_mv | AT tsaurigor correctiontoimmunotherapyinprostatecancernewhorizonofhurdlesandhopes AT brandtmaximilianp correctiontoimmunotherapyinprostatecancernewhorizonofhurdlesandhopes AT juengeleva correctiontoimmunotherapyinprostatecancernewhorizonofhurdlesandhopes AT manceaucecile correctiontoimmunotherapyinprostatecancernewhorizonofhurdlesandhopes AT ploussardguillaume correctiontoimmunotherapyinprostatecancernewhorizonofhurdlesandhopes |